In an official statement, G4S explained that the contract will initially be worth approximately GB pound 17 million per annum and, under its Terms and Conditions, G4S will centrally manage GSK’s security services from the UK.
According to the guarding giant, it will be “using a high quality approach which will deliver consistent, co-ordinated and efficient operations, training and standards under an initial roll-out across a number of GSK sites”.
G4S will be offering a broad range of security services “to ensure the right security solution is delivered for each site”.
Security in the UK and overseas
The initial roll-out covers the deployment of G4S employees to GSK sites across Argentina, Costa Rica, the UK, US and Venezuela, as well as a team which will secure GSK’s UK headquarters, which is located in Brentford.
Future roll-out plans include G4S securing sites in the additional 28 countries in which GSK operates – among them France and Belgium – across the next 12-18 months.
Commentating on this major contract win, David Taylor-Smith – CEO for G4S Secure Solutions (UK and Ireland) – told SMT Online: “We’re delighted to win this important strategic contract, and to be given the opportunity to combine our global capabilities and proven expertise such that we can provide the best possible security solutions to GSK.”
Taylor-Smith added: “As leading companies in our respective fields, both parties are very much looking forward to building on the strengths of this partnership, and helping GSK protect what is a globally respected brand.”
GSK at a glance
As a company, GSK’s mission is “to improve the quality of human life by enabling people to do more, feel better and live longer”.
GSK’s a research-based pharmaceutical company firmly committed to tackling the three ‘priority’ diseases identified by the World Health Organisation: HIV/AIDS, tuberculosis and malaria. To honour and support that commitment, the business employs just under 100,000 people in over 100 countries, the workforce making almost four billion packs of medicines and healthcare products every year.
Over 15,000 people work in GSK’s research teams to discover new medicines, and 65 million compounds are screened every year in the ongoing search for those medicines.
Many of its consumer brands, of course, are household names: Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax among them.
